Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shortened-duration Tacrolimus after Nonmyeloablative PBSCT
NCT02556931Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Dec 2015
- Primary completion
- Apr 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of tacrolimus + Wuzhi capsule in graft-versus-host disease (GVHD), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Dec 2015; status: completed.
02
Drugs
tacrolimus + Wuzhi capsule
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT02556931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02556931.